Journey Medical Corp. (DERM)
3.30
-0.25
(-7.04%)
USD |
NASDAQ |
Nov 20, 15:51
Journey Medical Total Liabilities (Quarterly) : 71.60M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 71.60M |
| June 30, 2026 | 66.24M |
| March 31, 2026 | 60.70M |
| December 31, 2025 | 62.74M |
| September 30, 2025 | 59.29M |
| June 30, 2025 | 61.91M |
| March 31, 2025 | 63.42M |
| December 31, 2024 | 60.17M |
| September 30, 2024 | 53.12M |
| June 30, 2024 | 53.89M |
| March 31, 2024 | 53.62M |
| December 31, 2023 | 56.50M |
| Date | Value |
|---|---|
| September 30, 2023 | 48.54M |
| June 30, 2023 | 69.74M |
| March 31, 2023 | 88.36M |
| December 31, 2022 | 88.18M |
| September 30, 2022 | 81.96M |
| June 30, 2022 | 78.70M |
| March 31, 2022 | 79.46M |
| December 31, 2021 | 55.24M |
| September 30, 2021 | 100.77M |
| June 30, 2021 | 73.52M |
| March 31, 2021 | |
| December 31, 2020 | 41.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Talphera, Inc. | 12.86M |
| Fortress Biotech, Inc. | 103.19M |
| Relmada Therapeutics, Inc. | 11.56M |
| Turn Therapeutics, Inc. | 10.66M |
| ANI Pharmaceuticals, Inc. | 930.55M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.85M |
| Shareholders Equity (Quarterly) | 32.25M |
| Debt to Equity Ratio | 0.7945 |
| Current Ratio | 1.481 |
| Net Debt Paydown Yield | -0.04% |